Sunday, October 30, 2016

CardioBrief: Impella No Better Than IABP in Cardiogenic Shock

(MedPage Today) -- Underpowered IMPRESS trial shows no mortality benefit
via CardioBrief: Impella No Better Than IABP in Cardiogenic Shock
by
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)